Related Experiment Video
Updated: May 9, 2026

Trabecular Bone Microarchitecture Evaluation in an Osteoporosis Mouse Model
Published on: September 8, 2023
Changes of microRNA profile and microRNA-mRNA regulatory network in bones of ovariectomized mice
Jee Hyun An1, Jung Hun Ohn, Jung Ah Song
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea.
Abstract:
Growing evidence shows the possibility of a role of microRNAs (miRNA) in regulating bone mass. We investigated the change of miRNAs and mRNA expression profiles in bone tissue in an ovariectomized mice model and evaluated the regulatory mechanism of bone mass mediated by miRNAs in an estrogen-deficiency state. Eight-week-old female C3H/HeJ mice underwent ovariectomy (OVX) or sham operation (Sham-op), and their femur and tibia were harvested to extract total bone RNAs after 4 weeks for microarray analysis. Eight miRNAs (miR-127, -133a, -133a*, -133b, -136, -206, -378, -378*) were identified to be upregulated after OVX, whereas one miRNA (miR-204) was downregulated. Concomitant analysis of mRNA microarray revealed that 658 genes were differentially expressed between OVX and Sham-op mice. Target prediction of differentially expressed miRNAs identified potential targets, and integrative analysis using the mRNA microarray results showed that PPARγ and CREB pathways are activated in skeletal tissues after ovariectomy. Among the potential candidates of miRNA, we further studied the role of miR-127 in vitro, which exhibited the greatest changes after OVX. We also studied the effects of miR-136, which has not been studied in the context of bone mass regulation. Transfection of miR-127 inhibitor has enhanced osteoblastic differentiation in UAMS-32 cells as measured by alkaline phosphatase activities and mRNA expression of osteoblast-specific genes, whereas miR-136 precursor has inhibited osteoblastic differentiation. Furthermore, transfection of both miR-127 and miR-136 inhibitors enhanced the osteocyte-like morphological changes and survival in MLO-Y4 cells, whereas precursors of miR-127 and -136 have aggravated dexamethasone-induced cell death. Both of the precursors enhanced osteoclastic differentiation in bone marrow macrophages, indicating that both miR-127 and -136 are negatively regulating bone mass. Taken together, these results suggest a novel insight into the association between distinct miRNAs expression and their possible role through regulatory network with mRNAs in the pathogenesis of estrogen deficiency-induced osteoporosis.
Insights
MicroRNAs (miRNAs) play a role in bone mass regulation. This study found that miR-127 and miR-136 negatively regulate bone mass in an estrogen-deficient state, offering insights into osteoporosis pathogenesis.
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- Estrogen deficiency, often due to ovariectomy (OVX), is a primary cause of osteoporosis.
- MicroRNAs (miRNAs) are increasingly recognized as regulators of bone metabolism.
- The specific roles of miRNAs in estrogen-deficiency-induced bone loss remain incompletely understood.
Purpose of the Study:
- To investigate changes in miRNA and mRNA expression profiles in bone tissue following ovariectomy.
- To elucidate the regulatory mechanisms of bone mass mediated by miRNAs in an estrogen-deficient state.
- To evaluate the functional roles of specific miRNAs, miR-127 and miR-136, in bone cell differentiation and survival.
Main Methods:
- Ovariectomy (OVX) and sham operations were performed on mice.
- Microarray analysis was used to assess miRNA and mRNA expression profiles in bone tissue.
- Bioinformatic tools predicted miRNA targets and analyzed pathway activation (PPARγ, CREB).
- In vitro studies involved transfecting cells with miRNA inhibitors and precursors to assess effects on osteoblast and osteocyte differentiation and survival, and osteoclast differentiation.
Main Results:
- OVX induced significant changes in miRNA expression, with eight upregulated (e.g., miR-127, miR-136) and one downregulated.
- 658 differentially expressed genes were identified between OVX and sham groups.
- Integrative analysis suggested activation of PPARγ and CREB pathways.
- In vitro, miR-127 inhibition enhanced osteoblastic differentiation, while miR-136 precursor inhibited it.
- Both miR-127 and miR-136 precursors promoted osteoclastic differentiation and aggravated cell death in osteocyte-like cells.
Conclusions:
- Distinct miRNA expression patterns are associated with estrogen deficiency-induced bone loss.
- miR-127 and miR-136 negatively regulate bone mass by influencing osteoblast and osteoclast differentiation.
- These findings highlight a novel miRNA-mRNA regulatory network in the pathogenesis of osteoporosis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Osteoclasts in Bone Remodeling

